Specifications
- Purity
- ≥97% (HPLC)
- Appearance
- Light grey powder
- Identity
- 1H-NMR
Properties
- Solvents
- acetone, DMSO
- Melting Point
- 176-178 °C
- Density
- 1.52 g/cm3
Documentation
- Safety Data Sheet (SDS)
- CDX H0053 MSDS.pdf
Available from stock
5-Hydroxydiclofenac
- SKU
- H0053
Category: API's & Intermediates
- Synonyms
- 2-[(2,6-Dichlorophenyl)amino]-5-hydroxybenzeneacetic acid , 5-OH-DFN , 5-OH DCF , BRN 4199419
- 69002-84-2
- CAS-Number
- C14H11Cl2NO3
- Molecular Formula
- 312.15
- Molecular Weight
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
- Shipping
- AMBIENT
- Short Term Storage
- +4°C
- Long Term Storage
- -20°C
- Handling Advice
- Protect from light and moisture.
- Use / Stability
- Stable for at least 2 years after receipt when stored at -20°C.
- Hazard statements
- H302-H315-H319-H335-H410
- Precautionary statements
- P273-P280-P301 + P312 + P330-P337 + P313-P391-P501
- GHS Symbol
- GHS07+GHS09
- Signal word
- Warning
- RIDADR
- UN3077 9
- Transportation
- Packing Group III
- Description
- Metabolite of Diclofenac, a nonsteroidal anti-inflammatory compound that functions via inhibiton of cyclooxygenase (COX). Diclofenac undergoes biotransformation not only by glucuronidation, but also by cytochrome P450–mediated oxidation to produce 4?-OH-DFN and 5-OH-DFN, which undergo subsequent oxidation to form highly electrophilic benzoquinone imine intermediates. Compound can be used as analytical reference material.
- Smiles
- OC1=CC=C(NC2=C(Cl)C=CC=C2Cl)C(CC(O)=O)=C1
- InChi Key
- VNQURRWYKFZKJZ-UHFFFAOYSA-N
- References
- (1) J.R. Kenny, et al. , J. Med. Chem. 47, 2816 (2004) , (2) D.J. Naisbitt, et al. , Toxicol. Lett. 168, 45 (2007) , (3) D. Stülten, et al. , Sci. Total Environ. 405, 310 (2008) , (4) D.J. Waldon, et al. , Chem. Res. Toxicol. 23, 1947 (2010) , (5) J. Surendradoss, et al. , Drug Metab. Disp. 42, 1834 (2014)
- InChi
- InChI=1S/C14H11Cl2NO3/c15-10-2-1-3-11(16)14(10)17-12-5-4-9(18)6-8(12)7-13(19)20/h1-6,17-18H,7H2,(H,19,20)
Metabolite of Diclofenac, a nonsteroidal anti-inflammatory compound that functions via inhibiton of cyclooxygenase (COX). Diclofenac undergoes biotransformation not only by glucuronidation, but also by cytochrome P450–mediated oxidation to produce 4?-OH-DFN and 5-OH-DFN, which undergo subsequent oxidation to form highly electrophilic benzoquinone imine intermediates. Compound can be used as analytical reference material.
Additional information
| Synonyms | 2-[(2,6-Dichlorophenyl)amino]-5-hydroxybenzeneacetic acid, 5-OH-DFN, 5-OH DCF, BRN 4199419 |
|---|---|
| Purity | ≥97% (HPLC) |
| Appearance | Light grey powder |
| CAS-Number | 69002-84-2 |
| Molecular Formula | C14H11Cl2NO3 |
| Molecular Weight | 312.15 |
| Identity | 1H-NMR |
| Solvents | acetone, DMSO |
| Melting Point | 176-178 °C |
| Density | 1.52 g/cm3 |
| Smiles | OC1=CC=C(NC2=C(Cl)C=CC=C2Cl)C(CC(O)=O)=C1 |
| InChi Key | VNQURRWYKFZKJZ-UHFFFAOYSA-N |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Hazard statements | H302-H315-H319-H335-H410 |
| Precautionary statements | P273-P280-P301 + P312 + P330-P337 + P313-P391-P501 |
| GHS Symbol | GHS07+GHS09 |
| Signal word | Warning |
| RIDADR | UN3077 9 |
| Transportation | Packing Group III |
| References | (1) J.R. Kenny, et al., J. Med. Chem. 47, 2816 (2004), (2) D.J. Naisbitt, et al., Toxicol. Lett. 168, 45 (2007), (3) D. Stülten, et al., Sci. Total Environ. 405, 310 (2008), (4) D.J. Waldon, et al., Chem. Res. Toxicol. 23, 1947 (2010), (5) J. Surendradoss, et al., Drug Metab. Disp. 42, 1834 (2014) |
| InChi | InChI=1S/C14H11Cl2NO3/c15-10-2-1-3-11(16)14(10)17-12-5-4-9(18)6-8(12)7-13(19)20/h1-6,17-18H,7H2,(H,19,20) |
| Quantity | 1 mg, 5 mg, Bulk |
